rapcabtagene autoleucel
novartis
['dlbcl', 'lymphoma', 'rapcabtagene', 'lymsm']
rapcabtagene autoleucel may elicit durable responses in patients with relapsed/refractory diffuse large b-cell lymphoma. #ash22 #lymsm #dlbcl 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.